Literature DB >> 11166958

Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine(1A) receptor mediated function in the rat.

H Razani1, Z Díaz-Cabiale, I Misane, F H Wang, K Fuxe, S O Ogren.   

Abstract

Galanin (3 nmol/rat), 2 h after its intracerebroventricular (i.c.v.) administration to male rats, attenuated the passive avoidance (PA) retention deficit induced by the 5-hydroxytryptamine (HT)(1A) receptor agonist 8-hydroxy-2-(di-N-propylamino)tetraline (8-OH-DPAT) (0.2 mg/kg) The reduction in the postjunctional 5-HT(1A) receptor-mediated response after i.c.v. galanin was not associated with changes in the mRNA levels and agonist binding properties of cortical limbic 5-HT(1A) receptors, believed to be the target receptors mediating the PA deficit caused by 8-OH-DPAT. These results suggest that acute increases of galanin transmission in vivo even after 2 h can counteract limbic 5-HT(1A) receptor-mediated responses of relevance for affective disorders without significantly affecting gene expression and binding characteristics of cortical limbic 5-HT(1A) receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166958     DOI: 10.1016/s0304-3940(00)01788-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.

Authors:  Chad J Swanson; Thomas P Blackburn; Xuexiang Zhang; Kang Zheng; Zhi-Qing David Xu; Tomas Hökfelt; Toni D Wolinsky; Michael J Konkel; Heidi Chen; Huailing Zhong; Mary W Walker; Douglas A Craig; Christophe P G Gerald; Theresa A Branchek
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

2.  GAL3 receptor KO mice exhibit an anxiety-like phenotype.

Authors:  Susanne M Brunner; Aitak Farzi; Felix Locker; Barbara S Holub; Meinrad Drexel; Florian Reichmann; Andreas A Lang; Johannes A Mayr; Jorge J Vilches; Xavier Navarro; Roland Lang; Günther Sperk; Peter Holzer; Barbara Kofler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-29       Impact factor: 11.205

Review 3.  Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Authors:  Sven Ove Ogren; Eugenia Kuteeva; Tomas Hökfelt; Jan Kehr
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression.

Authors:  Antonio Flores-Burgess; Carmelo Millón; Belen Gago; Laura García-Durán; Noelia Cantero-García; Araceli Puigcerver; José Angel Narváez; Kjell Fuxe; Luis Santín; Zaida Díaz-Cabiale
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

5.  On the existence and function of galanin receptor heteromers in the central nervous system.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Alexander O Tarakanov; Feliciano Calvo; Pere Garriga; Mercé Tena; Manuel Narvaez; Carmelo Millón; Concepción Parrado; Francisco Ciruela; Luigi F Agnati; José A Narvaez; Zaida Díaz-Cabiale
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-26       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.